Baohuoside I

Baohuoside I, a flavonoid isolated from Epimedium koreanum Nakai, acts as an inhibitor of CXCR4, downregulates CXCR4 expression, induces apoptosis and shows anti-tumor activity.

Product Specifications

CAS Number

[113558-15-9]

Product Name Alternative

Icariin-II; Icariside-II

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Apoptosis; CXCR

Type

Natural Products

Related Pathways

Apoptosis; GPCR/G Protein; Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer; Inflammation/Immunology; Endocrinology

Assay Protocol

https://www.medchemexpress.com/Baohuoside-I.html

Concentration

10mM

Purity

99.94

Solubility

DMSO : ≥ 32 mg/mL

Smiles

OC1=CC(O)=C2C(OC(C3=CC=C(OC)C=C3)=C(O[C@H](O[C@@H](C)[C@H](O)[C@H]4O)[C@@H]4O)C2=O)=C1C/C=C(C)\C

Molecular Formula

C27H30O10

Molecular Weight

514.52

Precautions

H302, H315, H319, H335

References & Citations

[1]Kim B, et al. Baohuoside I suppresses invasion of cervical and breast cancer cells through the downregulation of CXCR4 chemokine receptor expression. Biochemistry. 2014 Dec 9;53 (48) :7562-9.|[2]Song J, et al. Reactive oxygen species-mediated mitochondrial pathway is involved in Baohuoside I-induced apoptosis in human non-small cell lung cancer. Chem Biol Interact. 2012 Jul 30;199 (1) :9-17.|[3]Wang L, et al. The flavonoid Baohuoside-I inhibits cell growth and downregulates survivin and cyclin D1 expression in esophageal carcinoma via β-catenin-dependent signaling. Oncol Rep. 2011 Nov;26 (5) :1149-56.